Metabolic syndrome in obese Caucasian children: Prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors

C. Invitti, C. Maffeis, L. Gilardini, B. Pontiggia, G. Mazzilli, A. Girola, A. Sartorio, F. Morabito, G. C. Viberti

Research output: Contribution to journalArticle

Abstract

Objective: Studies on the prevalence of metabolic syndrome (MS) in European obese children using child-based criteria are scanty. Moreover, it is unknown if nontraditional cardiovascular disease (CVD) risk factors are associated with the MS at this early age in these subjects. Design and subjects: We studied the prevalence of the MS in 588 Caucasian obese children and adolescents by devising a World Health Organization derived definition and child-specific criteria, whose deviation from normalcy was based on an age, sex, and ethnically comparable control group of 1363 subjects. In a subgroup of 206 obese children, we investigated the association of the MS with nontraditional CVD risk factors. Measurements: Fasting blood samples for glucose and lipids measurements were taken in both control and obese children. In addition, the obese children underwent an oral glucose tolerance test. In the subgroup of 206 obese children, albumin excretion rate , plasma uric acid, fibrinogen, plasminogen activator inhibitor type 1(PAI-1), C-reactive protein, interleukin 6 and white blood cells were also measured. Results: The prevalence of MS was 23.3%. A similar prevalence of 23% of MS was recorded in the subgroup of 206 obese children in whom measurements of nontraditional CVD risk factors were available. After adjustment for the degree of obesity, subjects with MS had significantly higher uric acid (6.6 ± 0.23 vs 6.1 ± 0.12 mg/dl, P <0.0001) and PAI-1 plasma concentrations (231.4 ± 25.50 vs 214.3 ± 12.96 ng/ml, P <0.05) and a higher frequency of microalbuminuria (37 vs 20%, P <0.05) than those without MS. Microalbuminuria, uric acid and PAI-1 explained 10.6% of the variance of MS. Conclusion: Approximately, a quarter of Caucasian obese children have the MS. The association of MS with several nontraditional risk factors for CVD early in life suqqests a heightened CVD risk in these individuals.

Original languageEnglish
Pages (from-to)627-633
Number of pages7
JournalInternational Journal of Obesity
Volume30
Issue number4
DOIs
Publication statusPublished - Apr 2006

Fingerprint

metabolic syndrome
risk factors
cardiovascular diseases
Cardiovascular Diseases
Plasminogen Activator Inhibitor 1
uric acid
Uric Acid
C-reactive protein
fibrinogen
World Health Organization
Glucose Tolerance Test
interleukin-6
C-Reactive Protein
Fibrinogen
fasting
albumins
Blood Glucose
Albumins
Interleukin-6
Fasting

Keywords

  • Metabolic syndrome
  • Microalbuminuria
  • Obese children
  • PAI-1
  • Uric acid

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Public Health, Environmental and Occupational Health
  • Endocrinology
  • Food Science
  • Endocrinology, Diabetes and Metabolism

Cite this

Metabolic syndrome in obese Caucasian children : Prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors. / Invitti, C.; Maffeis, C.; Gilardini, L.; Pontiggia, B.; Mazzilli, G.; Girola, A.; Sartorio, A.; Morabito, F.; Viberti, G. C.

In: International Journal of Obesity, Vol. 30, No. 4, 04.2006, p. 627-633.

Research output: Contribution to journalArticle

@article{eef660facc13405fa0c1165bb2ca1a75,
title = "Metabolic syndrome in obese Caucasian children: Prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors",
abstract = "Objective: Studies on the prevalence of metabolic syndrome (MS) in European obese children using child-based criteria are scanty. Moreover, it is unknown if nontraditional cardiovascular disease (CVD) risk factors are associated with the MS at this early age in these subjects. Design and subjects: We studied the prevalence of the MS in 588 Caucasian obese children and adolescents by devising a World Health Organization derived definition and child-specific criteria, whose deviation from normalcy was based on an age, sex, and ethnically comparable control group of 1363 subjects. In a subgroup of 206 obese children, we investigated the association of the MS with nontraditional CVD risk factors. Measurements: Fasting blood samples for glucose and lipids measurements were taken in both control and obese children. In addition, the obese children underwent an oral glucose tolerance test. In the subgroup of 206 obese children, albumin excretion rate , plasma uric acid, fibrinogen, plasminogen activator inhibitor type 1(PAI-1), C-reactive protein, interleukin 6 and white blood cells were also measured. Results: The prevalence of MS was 23.3{\%}. A similar prevalence of 23{\%} of MS was recorded in the subgroup of 206 obese children in whom measurements of nontraditional CVD risk factors were available. After adjustment for the degree of obesity, subjects with MS had significantly higher uric acid (6.6 ± 0.23 vs 6.1 ± 0.12 mg/dl, P <0.0001) and PAI-1 plasma concentrations (231.4 ± 25.50 vs 214.3 ± 12.96 ng/ml, P <0.05) and a higher frequency of microalbuminuria (37 vs 20{\%}, P <0.05) than those without MS. Microalbuminuria, uric acid and PAI-1 explained 10.6{\%} of the variance of MS. Conclusion: Approximately, a quarter of Caucasian obese children have the MS. The association of MS with several nontraditional risk factors for CVD early in life suqqests a heightened CVD risk in these individuals.",
keywords = "Metabolic syndrome, Microalbuminuria, Obese children, PAI-1, Uric acid",
author = "C. Invitti and C. Maffeis and L. Gilardini and B. Pontiggia and G. Mazzilli and A. Girola and A. Sartorio and F. Morabito and Viberti, {G. C.}",
year = "2006",
month = "4",
doi = "10.1038/sj.ijo.0803151",
language = "English",
volume = "30",
pages = "627--633",
journal = "International Journal of Obesity",
issn = "0307-0565",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Metabolic syndrome in obese Caucasian children

T2 - Prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors

AU - Invitti, C.

AU - Maffeis, C.

AU - Gilardini, L.

AU - Pontiggia, B.

AU - Mazzilli, G.

AU - Girola, A.

AU - Sartorio, A.

AU - Morabito, F.

AU - Viberti, G. C.

PY - 2006/4

Y1 - 2006/4

N2 - Objective: Studies on the prevalence of metabolic syndrome (MS) in European obese children using child-based criteria are scanty. Moreover, it is unknown if nontraditional cardiovascular disease (CVD) risk factors are associated with the MS at this early age in these subjects. Design and subjects: We studied the prevalence of the MS in 588 Caucasian obese children and adolescents by devising a World Health Organization derived definition and child-specific criteria, whose deviation from normalcy was based on an age, sex, and ethnically comparable control group of 1363 subjects. In a subgroup of 206 obese children, we investigated the association of the MS with nontraditional CVD risk factors. Measurements: Fasting blood samples for glucose and lipids measurements were taken in both control and obese children. In addition, the obese children underwent an oral glucose tolerance test. In the subgroup of 206 obese children, albumin excretion rate , plasma uric acid, fibrinogen, plasminogen activator inhibitor type 1(PAI-1), C-reactive protein, interleukin 6 and white blood cells were also measured. Results: The prevalence of MS was 23.3%. A similar prevalence of 23% of MS was recorded in the subgroup of 206 obese children in whom measurements of nontraditional CVD risk factors were available. After adjustment for the degree of obesity, subjects with MS had significantly higher uric acid (6.6 ± 0.23 vs 6.1 ± 0.12 mg/dl, P <0.0001) and PAI-1 plasma concentrations (231.4 ± 25.50 vs 214.3 ± 12.96 ng/ml, P <0.05) and a higher frequency of microalbuminuria (37 vs 20%, P <0.05) than those without MS. Microalbuminuria, uric acid and PAI-1 explained 10.6% of the variance of MS. Conclusion: Approximately, a quarter of Caucasian obese children have the MS. The association of MS with several nontraditional risk factors for CVD early in life suqqests a heightened CVD risk in these individuals.

AB - Objective: Studies on the prevalence of metabolic syndrome (MS) in European obese children using child-based criteria are scanty. Moreover, it is unknown if nontraditional cardiovascular disease (CVD) risk factors are associated with the MS at this early age in these subjects. Design and subjects: We studied the prevalence of the MS in 588 Caucasian obese children and adolescents by devising a World Health Organization derived definition and child-specific criteria, whose deviation from normalcy was based on an age, sex, and ethnically comparable control group of 1363 subjects. In a subgroup of 206 obese children, we investigated the association of the MS with nontraditional CVD risk factors. Measurements: Fasting blood samples for glucose and lipids measurements were taken in both control and obese children. In addition, the obese children underwent an oral glucose tolerance test. In the subgroup of 206 obese children, albumin excretion rate , plasma uric acid, fibrinogen, plasminogen activator inhibitor type 1(PAI-1), C-reactive protein, interleukin 6 and white blood cells were also measured. Results: The prevalence of MS was 23.3%. A similar prevalence of 23% of MS was recorded in the subgroup of 206 obese children in whom measurements of nontraditional CVD risk factors were available. After adjustment for the degree of obesity, subjects with MS had significantly higher uric acid (6.6 ± 0.23 vs 6.1 ± 0.12 mg/dl, P <0.0001) and PAI-1 plasma concentrations (231.4 ± 25.50 vs 214.3 ± 12.96 ng/ml, P <0.05) and a higher frequency of microalbuminuria (37 vs 20%, P <0.05) than those without MS. Microalbuminuria, uric acid and PAI-1 explained 10.6% of the variance of MS. Conclusion: Approximately, a quarter of Caucasian obese children have the MS. The association of MS with several nontraditional risk factors for CVD early in life suqqests a heightened CVD risk in these individuals.

KW - Metabolic syndrome

KW - Microalbuminuria

KW - Obese children

KW - PAI-1

KW - Uric acid

UR - http://www.scopus.com/inward/record.url?scp=33645462246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645462246&partnerID=8YFLogxK

U2 - 10.1038/sj.ijo.0803151

DO - 10.1038/sj.ijo.0803151

M3 - Article

C2 - 16570092

AN - SCOPUS:33645462246

VL - 30

SP - 627

EP - 633

JO - International Journal of Obesity

JF - International Journal of Obesity

SN - 0307-0565

IS - 4

ER -